Table 3.
Method | ACC | SEN | SPE | AUC | P-value |
---|---|---|---|---|---|
Baseline-SVM | 89.35±8.83 | 90.39 | 88.27 | 0.94 | <0.001 |
LASSO-SVM | 87.57±9.12 | 89.02 | 86.15 | 0.95 | <0.001 |
t-test-SVM | 86.75±10.33 | 83.92 | 89.42 | 0.93 | <0.001 |
Baseline-MK-SVM | 94.53±6.55 | 94.90 | 94.04 | 0.96 | <0.001 |
LASSO-MK-SVM | 93.74±7.81 | 95.00 | 91.60 | 0.97 | <0.001 |
t-test-MK-SVM | 93.45±7.35 | 94.90 | 91.92 | 0.96 | <0.001 |
Group Lasso-MK-SVM | 94.53±6.80 | 94.90 | 94.04 | 0.96 | <0.001 |
Euclid-MK-SVM | 95.08±6.77 | 97.25 | 92.88 | 0.97 | 0.004 |
Hypergraph-MK-SVM | 94.77±6.39 | 97.25 | 92.31 | 0.97 | <0.001 |
MFCC-MK-SVM | 97.60±5.03 | 98.43 | 96.73 | 0.98 | -- |
(b) MCI versus NC | |||||
Method | ACC | SEN | SPE | AUC | P-value |
Baseline-SVM | 70.75±10.04 | 79.80 | 53.46 | 0.76 | <0.001 |
LASSO-SVM | 72.46±11.05 | 83.03 | 52.31 | 0.78 | <0.001 |
t-test-SVM | 72.79±9.53 | 85.96 | 47.69 | 0.77 | <0.001 |
Baseline-MK-SVM | 80.09±8.24 | 87.47 | 65.96 | 0.79 | <0.001 |
LASSO-MK-SVM | 81.89±8.89 | 90.24 | 62.27 | 0.79 | 0.022 |
t-test-MK-SVM | 81.71±9.43 | 91.82 | 62.31 | 0.79 | 0.019 |
Group Lasso-MK-SVM | 79.76±6.91 | 95.76 | 49.23 | 0.77 | <0.001 |
Euclid-MK-SVM | 81.48±8.48 | 89.49 | 66.15 | 0.80 | 0.007 |
Hypergraph-MK-SVM | 81.20±6.55 | 94.14 | 56.54 | 0.75 | <0.001 |
MFCC-MK-SVM | 84.47±6.83 | 94.04 | 66.15 | 0.81 | -- |
(c) MCI-C versus MCI-NC | |||||
Method | ACC | SEN | SPE | AUC | P-value |
Baseline-SVM | 53.95±15.12 | 44.65 | 61.07 | 0.59 | <0.001 |
LASSO-SVM | 54.57±14.87 | 45.12 | 61.79 | 0.60 | <0.001 |
t-test-SVM | 50.76±13.74 | 34.42 | 63.39 | 0.57 | <0.001 |
Baseline-MK-SVM | 69.17±12.77 | 57.44 | 78.04 | 0.66 | <0.001 |
LASSO-MK-SVM | 71.88±13.36 | 61.97 | 76.00 | 0.66 | <0.001 |
t-test-MK-SVM | 63.05±12.60 | 50.70 | 72.32 | 0.59 | <0.001 |
Group Lasso-MK-SVM | 70.86±11.37 | 62.33 | 77.14 | 0.65 | <0.001 |
Euclid-MK-SVM | 72.00±12.97 | 69.77 | 73.57 | 0.70 | <0.001 |
Hypergraph-MK-SVM | 73.64±11.19 | 66.28 | 79.11 | 0.74 | 0.008 |
MFCC-MK-SVM | 77.76±10.59 | 67.44 | 85.54 | 0.76 | -- |